Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Pierrel Research USA Launches Orablocâ„¢ a New Purer Articaine

May 10, 2011 By Bio-Medicine.Org

WAYNE, Pa., May 10, 2011 /PRNewswire/ — Pierrel Research USA,
Inc. (www.pierrel-research-usa.com),
a subsidiary of Pierrel SpA, the Italian-based, global
pharmaceutical services company (www.pierrel.it), announces the US
launch of Orabloc™ (Articaine hydrochloride 4% with
epinephrine 1:100,000 and Articaine hydrochloride 4% with
epinephrine 1:200,000). Orabloc is a new purer formulation of
Articaine with epinephrine, an injectable dental anesthetic for
routine dental procedures and oral surgery.

“With the availability of Orabloc, US dentists will now have
a purer choice in Articaine anesthetics,”
said Canio Mazzaro,
Chairman, and CEO of Pierrel SpA. “Up to this point, all
available US brands of Articaine are manufactured in Canada using
the terminal sterilization method. Pierrel manufactures Orabloc
using an aseptic method in our FDA-approved facility in Capua,
Italy and the result is a purer formulation of Articaine. Orabloc
is an Articaine with
less degradation products and
impurities such as articaine acid and epinephrine sulphonic acid.
What’s more, Orabloc
requires less overage of epinephrine,
so there is less vasoconstrictor in each injection. Less
vasoconstrictor is clearly more
desirable and is consistent
with recommendations from the American Heart Association to use the
lowest available amount
of vasoconstrictor.”

Mr. Mazzaro went on to say, “Orabloc is not only the first
aseptically manufactured Articaine available in the US, it is one
of the few Italian pharmaceutical products approved by FDA in the
last 30 years. The approval clearly shows the need and value of
Orabloc as its approval in the US is now joined by approvals in
Canada, Italy, and Russia with approvals pending in Germany, UK,
France, Austria, and Poland.”

According to Bernardo Verrengia, Scientific and Regulatory
Advisor for P

‘/>”/>

SOURCE

Related Articles Read More >

Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I
Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech